Jailendra Singh
Stock Analyst at Truist Securities
(0.95)
# 3,935
Out of 5,105 analysts
185
Total ratings
29.59%
Success rate
-23.91%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Buy | $30 → $31 | $24.82 | +24.90% | 8 | Nov 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $16 → $10 | $3.94 | +153.81% | 8 | Nov 10, 2025 | |
| IQV IQVIA Holdings | Reiterates: Buy | $235 → $265 | $225.98 | +17.27% | 17 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Buy | $35 → $36 | $16.04 | +124.44% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $37.77 | -2.04% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $189.93 | +23.20% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $566.15 | -22.99% | 5 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $32.46 | +57.12% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $26.01 | +3.81% | 10 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $44.13 | +38.23% | 9 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $49.79 | -3.60% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $7.62 | +18.11% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.79 | +97.13% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $4.35 | +72.41% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $22.46 | +104.81% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $229.49 | -8.49% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $9.92 | +41.13% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.72 | +802.15% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.07 | +219.41% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $2.95 | +1,357.63% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.30 | +943.48% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.51 | +164.90% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $198.32 | -70.75% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $3.26 | +1,280.37% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $815.54 | -59.17% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.75 | +227.27% | 2 | May 19, 2021 |
Privia Health Group
Nov 10, 2025
Reiterates: Buy
Price Target: $30 → $31
Current: $24.82
Upside: +24.90%
Evolent Health
Nov 10, 2025
Maintains: Buy
Price Target: $16 → $10
Current: $3.94
Upside: +153.81%
IQVIA Holdings
Oct 29, 2025
Reiterates: Buy
Price Target: $235 → $265
Current: $225.98
Upside: +17.27%
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $16.04
Upside: +124.44%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $37.77
Upside: -2.04%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $189.93
Upside: +23.20%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $566.15
Upside: -22.99%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $32.46
Upside: +57.12%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $26.01
Upside: +3.81%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $44.13
Upside: +38.23%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $49.79
Upside: -3.60%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $7.62
Upside: +18.11%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.79
Upside: +97.13%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $4.35
Upside: +72.41%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $22.46
Upside: +104.81%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $229.49
Upside: -8.49%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $9.92
Upside: +41.13%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.72
Upside: +802.15%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.07
Upside: +219.41%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $2.95
Upside: +1,357.63%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.30
Upside: +943.48%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.51
Upside: +164.90%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $198.32
Upside: -70.75%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $3.26
Upside: +1,280.37%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $815.54
Upside: -59.17%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.75
Upside: +227.27%